Identification of a nuclear transcriptional module associated with ERα and E2F/FOXM1 signaling across PAM50 breast cancer subtypes
The 34-gene panel is proposed as a candidate transcriptional framework that may provide insights into BC subtype-discrimination and potential utility as a biomarker signature for breast cancer stratification.